-
BioSig Technologies (BSGM) Prices 1.57M Share Offering at $1.91/sh
-
BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
BioSig Technologies (BSGM) Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders
-
BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders
-
BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent
-
BioSig Technologies (BSGM) Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately
-
BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately
-
BioSig Engages Consulting Firm for Business Model Strategies
-
BioSig Engages Consulting Firm for Business Model Strategies
-
BioSig Technologies (BSGM) Announces Reduction of its Workforce
-
BioSig Technologies (BSGM) to Cut Staff, Substantially Reduce Business Operations
-
BioSig Announces Reduction of its Workforce
-
BioSig Announces Reduction of its Workforce
-
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases
-
BioSig Technologies (BSGM) plans workforce reduction, shifts its core strategy
-
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy

